Multicenter outcomes-based evaluation of the vitros® immunodiagnostic products anti-HCV reagent pack and calibrator (vitros anti-HCV assay) in patients with signs and symptoms of hepatitis and in patients at risk for hepatitis C infection: John V Calcagno, Ortho-Clinical Diagnostics, Raritan, NJ; Eugene Schiff, Univ of Miami Center for Liver Diseases, Miami, FL; Jane Latimer, Parkland Memorial Hosp, Dept of Pathology, Dallas, TX; Denise Uettwiller-Geiger, The John T Mather Memorial Hosp, Port Jefferson, NY; Bashar M Attar, Cook County Hosp, Division of Gastroenterology, Chicago, IL; Gary Gitnick, UCLA Dept of Medicine, Division of Digestive Diseases, Los Angeles, CA; Jed B Gorlin, Memorial Blood Centers of Minnesota, Minneapolis, MN; Hector J Rodriguez, Cedars-Sinai Dialysis Services, Beverly Hills, CA; Gloria Sze, Harbor UCLA Medical Center, Torrance, CA; Helen Schneider, John Peterson, Lynn Bergmeyer, Ortho-Clinical Diagnostics, Raritan, NJ